We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BPTH market cap is 1.61M. The company's latest EPS is USD -6.2997 and P/E is -0.10.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.24M | -3.28M | -3.03M | -3.7M | -3.04M |
Net Income | -4.23M | -3.2M | -3.37M | -3.16M | -1.87M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 10.44M | 0 | 0 |
Operating Income | -8.69M | -10.91M | 0 | -13.9M | -15.84M |
Net Income | -8.6M | -10.88M | 21.65M | -13.87M | -16.08M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 6.52M | 5.02M | 3.22M | 1.77M | 5.12M |
Total Liabilities | 1.48M | 2.5M | 2.78M | 4.39M | 3.83M |
Total Equity | 5.04M | 2.53M | 441k | -2.63M | 1.29M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 22.66M | 16.48M | 26.57M | 15.97M | 3.22M |
Total Liabilities | 1.57M | 1.41M | 1.11M | 1.8M | 2.78M |
Total Equity | 21.09M | 15.07M | 25.46M | 14.17M | 441k |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -6.94M | -9.72M | -11.54M | -1.04M | -4.27M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | 1.69M | 2.2M | 174k | 7.22M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -8.36M | -10.96M | -9.92M | -15.1M | -11.54M |
Investing | N/A | N/A | -70k | -21k | N/A |
Financing | 27.78M | 4.29M | 20.01M | 1.73M | 2.2M |
Market Cap | 1.61M |
Price to Earnings Ratio | -0.10 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.48 |
Price to Book Ratio | 3.53 |
Dividend Yield | - |
Shares Outstanding | 2.55M |
Average Volume (1 week) | 55.92k |
Average Volume (1 Month) | 58.03k |
52 Week Change | -94.42% |
52 Week High | 12.00 |
52 Week Low | 0.61 |
Spread (Intraday) | 0.02 (2.38%) |
Company Name | Bio Path Holdings Inc |
Address |
108 lakeland ave dover, delaware 19901 |
Website | https://www.biopathholdings.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions